Investment Summary |
|
|---|---|
| Date | 2023-06-22 |
| Target | MESI |
| Sector | Medical Products |
| Investor(s) | SHS Capital |
| Deal Type | Growth Capital |
| Advisor(s) | Carlsquare (Financial) ODI Law (Legal) |
SEARCH BY
SHS Capital is a private equity firm focused on the healthcare sector. Specific areas of interest include life science, medical technology, diagnostics, applied technologies, digital health, and industrial biotechnology. The Firm will consider opportunities at all company stages and looks to commit up to €50 million in businesses valued up to €150 million. Target geographies include Germany, Austria, Switzerland, Scandinavia, and Benelux. SHS Capital was established in 1993 and is headquartered in Tubingen, Germany.
| DEAL STATS | # |
|---|---|
| Overall | 33 of 35 |
| Sector: Medical Products M&A | 19 of 19 |
| Type: Growth Capital M&A Deals | 21 of 21 |
| Country: Slovenia M&A | 1 of 1 |
| Year: 2023 M&A | 2 of 4 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2023-03-02 |
Simulands
Zurich, Switzerland Simulands is a medical simulation company focused on developing and commercializing innovative simulation solutions for healthcare training. Simulands leveraging longstanding expertise of medical devices development, and novel manufacturing techniques seeking to revolutionize R&D and Education in the cardiovascular space. Simulators offer solutions that are more practical, cost effective, and ethical versus traditional animal research practices. Simulands was founded in 2019 and is based in Zurich, Switzerland. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2023-06-27 |
Spiegelberg
Hamburg, Germany Spiegelberg is a medical equipment producer that manufactures specialized devices, catheters, and probes for neurosurgical use in the brain. Spiegelberg was founded in 1986 and is based in Hamburg, Germany. |
Sell | - |
